Interestingly, the inhibition of JAK and PI3K reduced MICA/B and PD-L1 expression to levels even lower than those in the control groups (Fig. 3E), suggesting constitutive activation of the JAK/STAT3 and PI3K/AKT pathways in MM. The gene discussed is STAT3; the disease is Miyoshi myopathy.